These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7478592)
1. The proline-rich region of Vav binds to Grb2 and Grb3-3. Ramos-Morales F; Romero F; Schweighoffer F; Bismuth G; Camonis J; Tortolero M; Fischer S Oncogene; 1995 Oct; 11(8):1665-9. PubMed ID: 7478592 [TBL] [Abstract][Full Text] [Related]
2. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Xu XX; Yi T; Tang B; Lambeth JD Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023 [TBL] [Abstract][Full Text] [Related]
3. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042 [TBL] [Abstract][Full Text] [Related]
4. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Ramos-Morales F; Druker BJ; Fischer S Oncogene; 1994 Jul; 9(7):1917-23. PubMed ID: 8208538 [TBL] [Abstract][Full Text] [Related]
5. SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin. Hobert O; Schilling JW; Beckerle MC; Ullrich A; Jallal B Oncogene; 1996 Apr; 12(7):1577-81. PubMed ID: 8622875 [TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin. Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825 [TBL] [Abstract][Full Text] [Related]
7. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2. VanderNoot VA; Fitzpatrick FA Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605 [TBL] [Abstract][Full Text] [Related]
8. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling. Najib S; Sánchez-Margalet V J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020 [TBL] [Abstract][Full Text] [Related]
9. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. Smit L; van der Horst G; Borst J J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483 [TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells. Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749 [TBL] [Abstract][Full Text] [Related]
11. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2. Charest A; Wagner J; Kwan M; Tremblay ML Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity. Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970 [TBL] [Abstract][Full Text] [Related]
14. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Fan MM; Tamburic L; Shippam-Brett C; Zagrodney DB; Astell CR Virology; 2001 Dec; 291(2):285-91. PubMed ID: 11878897 [TBL] [Abstract][Full Text] [Related]
15. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells. Okumura K; Kaneko Y; Nonoguchi K; Nishiyama H; Yokoi H; Higuchi T; Itoh K; Yoshida O; Miki T; Fujita J Oncogene; 1997 Feb; 14(6):713-20. PubMed ID: 9038379 [TBL] [Abstract][Full Text] [Related]
16. The crystal structure of the N-terminal SH3 domain of Grb2. Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246 [TBL] [Abstract][Full Text] [Related]
17. Vav: function and regulation in hematopoietic cell signaling. Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692 [TBL] [Abstract][Full Text] [Related]
18. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Groysman M; Nagano M; Shaanan B; Katzav S Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237 [TBL] [Abstract][Full Text] [Related]
19. The signal transduction through Grb2/Ash in hematopoietic cells. Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406 [TBL] [Abstract][Full Text] [Related]
20. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells. Yoon SY; Koh WS; Lee MK; Park YM; Han MY Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]